uMedical
Medicines
Substances
Companies
Statistics
Menu
All medicines
Rivastigmine 3M Health Care Ltd
Withdrawn
Human
Details
EMA number
EMEA/H/C/003824
ATC code
N06DA03
Authorisation
3 April 2014
Withdrawn
19 August 2014
Revision
1
EMA page
Therapeutic indication
Symptomatic treatment of mild to moderately severe Alzheimer's dementia.
MeSH:
Alzheimer Disease
Group:
Psychoanaleptics;Anticholinesterases
Active substances
rivastigmine
Marketing Authorisation Holder
3M Health Care Limited
MAH
Timeline
Filter by authority:
EMA
Rivastigmine 3M Health Care Ltd withdrawn
19 Aug 2014
withdrawn
regulatory
Rivastigmine 3M Health Care Ltd authorised
3 Apr 2014
authorised
regulatory
Rivastigmine 3M Health Care Ltd | uMedical